Publications
Filters: Author is Navarro, M [Clear All Filters]
Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome. European journal of human genetics : EJHG. 2012. Abstract
UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy. British journal of cancer. 2010;103(4):581-9. Abstract
Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection. Carcinogenesis. 2007;28(6):1241-6.
Colonoscopic findings from a pilot screening study for colorectal cancer in Catalonia . Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2008;100(6):343-8. Abstract
Colorectal cancer screening: strategies to select populations with moderate risk for disease. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2009;101(12):855-60. Abstract
Colorectal cancer in a population with a guaiac-based screening programme . Medicina clinica. 2009;132(13):495-500. Abstract
Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer. International journal of colorectal disease. 2008;23(1):21-7.
Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). Journal of medical screening. 2007;14(2):81-6. Abstract
Colorectal cancer mortality in Spain: trends and projections for 1985-2019. European journal of gastroenterology & hepatology. 2009;21(1):92-100. Abstract
Clinicopathological risk factors of Stage II colon cancer: results of a prospective study. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2013;15(4):414-22. Abstract
